BERKELEY, CA, October 25, 2023 - InterX Inc., a subsidiary of NeoTX, using its proprietary AI technology, has achieved a monumental milestone in modelling biology, energy, and other important areas. The breakthrough has been heralded as the holy grail of computational molecular science. the achievement is published in https://pubs.acs.org/doi/full/10.1021/jacs.3c07628

InterX (https://www.research.interxinc.com) is a fully owned subsidiary of NeoTX (https://neotx.com).

About InterX Inc.
InterX Inc. is creating the technology to perform molecular simulations with chemical accuracy. The company and its Nobel Prize-winning team is applying the technology to real-world problems in Pharma, Biochemistry and Material Science. For further information about InterX refer to https://www.research.interxinc.com. InterX is a fully owned subsidiary of NeoTX (https://neotx.com).

Contact Information
Erik Ven
InterX Inc./NeoTX
Berkeley, CA
USA
Voice: (973) 908-2216